BCN-28679-59440
2 vaccinations
4 coded responses
26 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 625 / IL
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
-
2020-12-30
Survey response — day 0, dose 1MedDRA: Blood pressure increased, Chest discomfort, Immediate post-injection reaction, Medical observation, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Experienced heart racing and chest tightness within 5 minutes of receiving injection. Subsided within minutes but BP elevated. · Healthcare visit (other): Onsite assessment by EMSMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Report sent to call center — day 0, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Redness and itching at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
- 2021-01-20
- 2021-01-27
-
2021-01-29
Dose 2 — Moderna
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-02-26
Survey response — day 28, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rash on entire torsoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-05
-
2021-03-12
Survey response — day 42, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Continued rash on torso that never resolved with first round of oral steroids. Currently still on second round of steroids. Rash is improving but unsure if it will worsen again when steroids discontinued.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-30
- 2021-07-30
- 2021-07-30
- 2022-01-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Experienced heart racing and chest tightness within 5 minutes of receiving injection. Subsided within minutes but BP elevated.
Healthcare visit (other): Onsite assessment by EMS
Release 1 — day 14, dose 1
Symptoms: Redness and itching at injection site
Release 4 — day 28, dose 2
Symptoms: Rash on entire torso
Release 5 — day 42, dose 2
Symptoms: Continued rash on torso that never resolved with first round of oral steroids. Currently still on second round of steroids. Rash is improving but unsure if it will worsen again when steroids discontinued.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical observation | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Blood pressure increased | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Palpitations | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release